Several demographic and neuropathological variables including age, ARTAG, cerebrovascular disease, hippocampal atrophy, Braak NFT stage, and p-tau computer assessments were significantly associated with cognitive impairment in our PART cohort. The gene discussed is MAPT; the disease is hippocampal atrophy.